Lithium succinate

From Wikipedia, the free encyclopedia

Lithium succinate
Systematic (IUPAC) name
lithium butanedioic acid
Identifiers
CAS number  ?
ATC code D11AX04
PubChem 65248
Chemical data
Formula C4H5LiO4
Mol. mass 124.02 g/mol
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life  ?
Excretion  ?
Therapeutic considerations
Pregnancy cat.

?
Legal status
Routes  ?

Lithium succinate, the lithium salt of succinic acid, is a drug used in the treatment of seborrhoeic dermatitis[1] and proposed for the treatment of anogenital warts.[2]

[edit] References

  1. ^ Leeming JP (1993). "Use of topical lithium succinate in the treatment of seborrhoeic dermatitis". Dermatology (Basel) 187 (2): 149–50. PMID 8358107. 
  2. ^ Ward KA, Armstrong KD, Maw RD, Winther MD, Gilburt SJ, Dinsmore WW (1997). "A pilot study to investigate the treatment of anogenital warts with Topical Lithium Succinate cream (8% lithium succinate, 0.05% zinc sulphate)". International journal of STD & AIDS 8 (8): 515–7. PMID 9259500. 


Tablets  This pharmacology-related article is a stub. You can help Wikipedia by expanding it.
v • d • e
Other dermatological preparations (D11)
Medicated shampoos
Cetrimide - Cadmium compounds - Selenium compounds - Povidone-iodine - Sulfur compounds - Xenysalate
Other dermatologicals